Delivery Order SPE2DB22D3016-SPE2DB24FAZN2
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Buprenorphine 10 MCG/HR Patch 4S, a medication used for pain management. The contract, valued at $1,968.62, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the Defense Logistics Agency (DLA) Troop Support Medical, valued at up...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Buprenorphine 20 MCG/HR Patch 4S. The $1,946.84 firm fixed-price contract has a completion date of June 21, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $4,309.74, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,497,090 units of Buprenorphine 15 MCG/HR Patch 4S, a specialty medication used for pain management. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award, with ID SPE2DX15D2213|SPE2DX24F7X9X, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,954,459 units of Buprenorphine 20 mcg/hr Patches. The award has a ceiling value of $1,056.00 and an ultimate completion date of December 1, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the delivery of Buprenorphine 20 mcg/hr Patch 4s, a specialty pharmaceutical product. The contract, valued at $1,060.77, has an ultimate completion date of April 21, 2023. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award is for the delivery of Buprenorphine 20 mcg/hr patches to the Defense Logistics Agency (DLA). The $1,658.72 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 13, 2023. The contract has an ultimate completion date of April 14, 2023 and was not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Buprenorphine 15 MCG/HR Patch 4S, a pain management medication, to the Defense Logistics Agency (DLA). The $2,422.28 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 1, 2021, with a completion date of November 2, 2021. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Buprenorphine 20 mcg/hr patches. The $1,033.34 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) and has a completion date of September 26, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,222.46 delivery order is for the supply of Buprenorphine 20 MCG/HR Patch 4S, a pharmaceutical product. The contract has a completion date of July 11, 2024 and is a firm fixed-price, delivery order type. Amerisourcebergen Drug Corp holds two relevant Indefinite Delivery Contracts (IDCs) with the federal government. The first is a single-award IDC with DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,178.60, is for the delivery of Buprenorphine 20 MCG/HR Patch 4S, a pharmaceutical product, to support military and government healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....